• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎(COVID-19)大流行期间急性心肌梗死相关的心源性休克发病率

Incidence of acute myocardial infarction-related cardiogenic shock during corona virus disease 19 (COVID-19) pandemic.

作者信息

Lauridsen M D, Butt J H, Østergaard L, Møller J E, Hassager C, Gerds T, Kragholm K, Phelps M, Schou M, Torp-Pedersen C, Gislason G, Køber L, Fosbøl E L

机构信息

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Department of Cardiology, Odense University Hospital, Odense, Denmark.

出版信息

Int J Cardiol Heart Vasc. 2020 Dec;31:100659. doi: 10.1016/j.ijcha.2020.100659. Epub 2020 Oct 13.

DOI:10.1016/j.ijcha.2020.100659
PMID:33072848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7553065/
Abstract

AIMS

The hospitalization of patients with MI has decreased during global lockdown due to the COVID-19 pandemic. Whether this decrease is associated with more severe MI, e.g. MI-CS, is unknown. We aimed to examine the association of Corona virus disease (COVID-19) pandemic and incidence of acute myocardial infarction with cardiogenic shock (MI-CS).

METHODS

On March 11, 2020, the Danish government announced national lock-down. Using Danish nationwide registries, we identified patients hospitalized with MI-CS. Incidence rates (IR) and incidence rate ratios (IRR) were used to compare MI-CS before and after March 11 in 2015-2019 and in 2020.

RESULTS

We identified 11,769 patients with MI of whom 696 (5.9%) had cardiogenic shock in 2015-2019. In 2020, 2132 MI patients were identified of whom 119 had cardiogenic shock (5.6%). The IR per 100,000 person years before March 11 in 2015-2019 was 9.2 (95% CI: 8.3-10.2) and after 8.9 (95% CI: 8.0-9.9). In 2020, the IR was 7.5 (95% CI: 5.8-9.7) before March 11 and 7.7 (95% CI: 6.0-9.9) after. The IRRs comparing the 2020-period with the 2015-2019 period before and after March 11 (lockdown) were 0.81 (95% CI: 0.59-1.12) and 0.87 (95% CI: 0.57-1.32), respectively. The IRR comparing the 2020-period during and before lockdown was 1.02 (95% CI: 0.74-1.41). No difference in 7-day mortality or in-hospital management was observed between study periods.

CONCLUSION

We could not identify a significant association of the national lockdown on the incidence of MI-CS, along with similar in-hospital management and mortality in patients with MI-CS.

摘要

目的

在因新冠疫情导致的全球封锁期间,心肌梗死(MI)患者的住院率有所下降。这种下降是否与更严重的心肌梗死,如心源性休克型心肌梗死(MI-CS)有关尚不清楚。我们旨在研究冠状病毒病(COVID-19)大流行与急性心肌梗死合并心源性休克(MI-CS)的发病率之间的关联。

方法

2020年3月11日,丹麦政府宣布全国封锁。利用丹麦全国性登记系统,我们确定了因MI-CS住院的患者。发病率(IR)和发病率比(IRR)用于比较2015 - 2019年以及2020年3月11日前后的MI-CS情况。

结果

我们确定了11769例心肌梗死患者,其中2015 - 2019年有696例(5.9%)发生心源性休克。2020年,确定了2132例心肌梗死患者,其中119例发生心源性休克(5.6%)。2015 - 2019年3月11日之前每10万人年的发病率为9.2(95%可信区间:8.3 - 10.2),之后为8.9(95%可信区间:8.0 - 9.9)。2020年,3月11日之前的发病率为7.5(95%可信区间:5.8 - 9.7),之后为7.7(95%可信区间:6.0 - 9.9)。将2020年期间与2015 - 2019年期间3月11日(封锁)前后进行比较的发病率比分别为0.81(95%可信区间:0.59 - 1.12)和0.87(95%可信区间:0.57 - 1.32)。比较2020年封锁期间和之前的发病率比为1.02(95%可信区间:0.74 - 1.41)。各研究期间在7天死亡率或住院治疗方面未观察到差异。

结论

我们未能确定全国封锁与MI-CS发病率之间存在显著关联,MI-CS患者的住院治疗和死亡率相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb4/7578681/6089de1dc808/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb4/7578681/79b987512e30/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb4/7578681/4c0689acec4d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb4/7578681/fc2c94de7de1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb4/7578681/6089de1dc808/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb4/7578681/79b987512e30/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb4/7578681/4c0689acec4d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb4/7578681/fc2c94de7de1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eb4/7578681/6089de1dc808/gr4.jpg

相似文献

1
Incidence of acute myocardial infarction-related cardiogenic shock during corona virus disease 19 (COVID-19) pandemic.新型冠状病毒肺炎(COVID-19)大流行期间急性心肌梗死相关的心源性休克发病率
Int J Cardiol Heart Vasc. 2020 Dec;31:100659. doi: 10.1016/j.ijcha.2020.100659. Epub 2020 Oct 13.
2
Outcomes among ST-Elevation Myocardial Infarction (STEMI) patients with cardiogenic shock and COVID-19: A nationwide analysis.伴有心源性休克和新冠肺炎的ST段抬高型心肌梗死(STEMI)患者的预后:一项全国性分析。
Am Heart J Plus. 2023 Jan;25:100243. doi: 10.1016/j.ahjo.2022.100243. Epub 2022 Dec 19.
3
Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.血管内微型轴流左心室辅助装置与主动脉内球囊泵在急性心肌梗死合并心源性休克患者中的应用与院内死亡率和大出血的关系。
JAMA. 2020 Feb 25;323(8):734-745. doi: 10.1001/jama.2020.0254.
4
Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded coronaries for Cardiogenic shocK?非ST段抬高型心肌梗死所致的心源性休克:来自SHOCK试验注册研究的报告。对于心源性休克,我们是否应紧急对闭塞冠状动脉进行血运重建?
J Am Coll Cardiol. 2000 Sep;36(3 Suppl A):1091-6. doi: 10.1016/s0735-1097(00)00888-3.
5
Nonroutine Use of Intra-Aortic Balloon Pump in Cardiogenic Shock Complicating Myocardial Infarction With Successful and Unsuccessful Primary Percutaneous Coronary Intervention.非计划性使用主动脉内球囊反搏在心肌梗死合并心原性休克中的应用:初次经皮冠状动脉介入治疗成功和失败的比较。
JACC Cardiovasc Interv. 2018 Sep 24;11(18):1885-1893. doi: 10.1016/j.jcin.2018.07.030.
6
Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States.美国急性心肌梗死合并非梗死相关心原性休克患者应用机械循环支持治疗的趋势和院内死亡率。
Clin Res Cardiol. 2018 Apr;107(4):287-303. doi: 10.1007/s00392-017-1182-2. Epub 2017 Nov 13.
7
Influence of cardiogenic shock with or without the use of intra-aortic balloon pump on mortality in patients with ST-segment elevation myocardial infarction.伴或不使用主动脉内球囊反搏的心源性休克对ST段抬高型心肌梗死患者死亡率的影响
Int J Cardiol Heart Vasc. 2014 Dec 30;6:19-24. doi: 10.1016/j.ijcha.2014.12.006. eCollection 2015 Mar 1.
8
Management and predictors of outcome in unselected patients with cardiogenic shock complicating acute ST-segment elevation myocardial infarction: results from the Bremen STEMI Registry.未选择患者的心源性休克合并急性 ST 段抬高型心肌梗死的管理和预后预测因素:不来梅 STEMI 注册研究结果。
Clin Res Cardiol. 2018 May;107(5):371-379. doi: 10.1007/s00392-017-1192-0. Epub 2017 Dec 11.
9
Fifteen-year trends in the management of cardiogenic shock and associated 1-year mortality in elderly patients with acute myocardial infarction: the FAST-MI programme.15 年来老年急性心肌梗死并发心源性休克患者的治疗方法及 1 年死亡率变化趋势:FAST-MI 研究计划。
Eur J Heart Fail. 2016 Sep;18(9):1144-52. doi: 10.1002/ejhf.585.
10
Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?溶栓、主动脉内球囊反搏及其联合应用对急性心肌梗死并发心源性休克的影响:SHOCK试验注册研究报告。对于心源性休克,我们是否应紧急对闭塞冠状动脉进行血运重建?
J Am Coll Cardiol. 2000 Sep;36(3 Suppl A):1123-9. doi: 10.1016/s0735-1097(00)00875-5.

引用本文的文献

1
A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19.新型冠状病毒肺炎合并 ST 段抬高型心肌梗死的研究进展
Heart Fail Clin. 2023 Apr;19(2):197-204. doi: 10.1016/j.hfc.2022.08.007.
2
Current situation of acute ST-segment elevation myocardial infarction in a county hospital chest pain center during an epidemic of novel coronavirus pneumonia.新型冠状病毒肺炎疫情期间某县级医院胸痛中心急性ST段抬高型心肌梗死的现状
Open Med (Wars). 2023 Jan 9;18(1):20220621. doi: 10.1515/med-2022-0621. eCollection 2023.
3
Recent highlights on myocarditis, cardiovascular complications of COVID-19, and cardiomyopathies from the International Journal of Cardiology: Heart & Vasculature.

本文引用的文献

1
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era.意大利 COVID-19 时代心肌梗死住院人数减少。
Eur Heart J. 2020 Jun 7;41(22):2083-2088. doi: 10.1093/eurheartj/ehaa409.
2
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.确认 COVID-19 重症 ICU 患者的血栓并发症累积发生率较高:更新分析。
Thromb Res. 2020 Jul;191:148-150. doi: 10.1016/j.thromres.2020.04.041. Epub 2020 Apr 30.
3
Impact of coronavirus disease 2019 (COVID-19) outbreak on outcome of myocardial infarction in Hong Kong, China.
《国际心脏病学杂志:心脏与血管》关于心肌炎、新冠病毒病的心血管并发症及心肌病的近期要点
Int J Cardiol Heart Vasc. 2022 Dec;43:101154. doi: 10.1016/j.ijcha.2022.101154. Epub 2022 Nov 22.
4
Is aortic thrombosis an intruder in the COVID pandemic?主动脉血栓形成是新冠疫情中的“闯入者”吗?
J Med Vasc. 2022 Oct;47(4):167-168. doi: 10.1016/j.jdmv.2022.10.002. Epub 2022 Oct 25.
5
Characteristics and outcomes of patients presenting with acute myocardial infarction and cardiogenic shock during COVID-19.在 COVID-19 期间出现急性心肌梗死和心源性休克的患者的特征和结局。
Catheter Cardiovasc Interv. 2022 Oct;100(4):568-574. doi: 10.1002/ccd.30390. Epub 2022 Sep 7.
6
A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19.新型冠状病毒肺炎合并 ST 段抬高型心肌梗死的研究进展
Cardiol Clin. 2022 Aug;40(3):321-328. doi: 10.1016/j.ccl.2022.03.007. Epub 2022 Mar 29.
7
Non-COVID outcomes associated with the coronavirus disease-2019 (COVID-19) pandemic effects study (COPES): A systematic review and meta-analysis.与 2019 年冠状病毒病(COVID-19)大流行影响研究(COPES)相关的非 COVID 结局:系统评价和荟萃分析。
PLoS One. 2022 Jun 24;17(6):e0269871. doi: 10.1371/journal.pone.0269871. eCollection 2022.
8
Hospitalization, major complications and mortality in acute myocardial infarction patients during the COVID-19 era: A systematic review and meta-analysis.COVID-19 大流行期间急性心肌梗死患者的住院治疗、主要并发症及死亡率:一项系统评价与荟萃分析
Int J Cardiol Heart Vasc. 2022 May 23;41:101058. doi: 10.1016/j.ijcha.2022.101058. eCollection 2022 Aug.
9
Hospitalizations and in-hospital outcomes in patients with ST-elevation myocardial infarction during the coronavirus disease 2019 pandemic: The Albanian experience.COVID-19 大流行期间 ST 段抬高型心肌梗死患者的住院和院内结局:阿尔巴尼亚的经验。
Anatol J Cardiol. 2022 Feb;26(2):118-126. doi: 10.5152/AnatolJCardiol.2021.486.
10
Myocardial infarction throughout 1 year of the COVID-19 pandemic: French nationwide study of hospitalization rates, prognosis and 90-day mortality rates.COVID-19 大流行期间的 1 年内心肌梗死:法国全国范围内的住院率、预后和 90 天死亡率研究。
Arch Cardiovasc Dis. 2021 Dec;114(12):768-780. doi: 10.1016/j.acvd.2021.10.008. Epub 2021 Nov 10.
新型冠状病毒病 2019(COVID-19)疫情对中国香港地区心肌梗死结局的影响。
Catheter Cardiovasc Interv. 2021 Feb 1;97(2):E194-E197. doi: 10.1002/ccd.28943. Epub 2020 May 5.
4
Misdiagnosis in the COVID-19 Era: When Zebras Are Everywhere, Don't Forget the Horses.新冠疫情时代的误诊:当到处都是“斑马”时,别忘了“马”。 (注:这里“斑马”和“马”是医学术语中罕见病和常见病的隐喻,意思是在疫情背景下,各种罕见症状出现时,也不能忽视常见疾病的诊断)
JACC Case Rep. 2020 Aug;2(10):1614-1619. doi: 10.1016/j.jaccas.2020.04.018. Epub 2020 Apr 27.
5
Management of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Statement From the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP).《COVID-19 大流行期间急性心肌梗死的管理:心血管血管造影和介入学会(SCAI)、美国心脏病学会(ACC)和美国急诊医师学会(ACEP)的立场声明》
J Am Coll Cardiol. 2020 Sep 15;76(11):1375-1384. doi: 10.1016/j.jacc.2020.04.039. Epub 2020 Apr 21.
6
Cardiovascular complications in COVID-19.COVID-19 中的心血管并发症。
Am J Emerg Med. 2020 Jul;38(7):1504-1507. doi: 10.1016/j.ajem.2020.04.048. Epub 2020 Apr 18.
7
Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic.新冠疫情期间美国ST段抬高型心肌梗死导管插入实验室激活率的降低
J Am Coll Cardiol. 2020 Jun 9;75(22):2871-2872. doi: 10.1016/j.jacc.2020.04.011. Epub 2020 Apr 10.
8
Myocardial localization of coronavirus in COVID-19 cardiogenic shock.COVID-19 心原性休克中冠状病毒的心肌定位。
Eur J Heart Fail. 2020 May;22(5):911-915. doi: 10.1002/ejhf.1828. Epub 2020 Apr 11.
9
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC's Interventional Council and SCAI.新型冠状病毒肺炎(COVID-19)大流行期间的心导管实验室考量:来自美国心脏病学会介入委员会和心血管造影和介入学会
J Am Coll Cardiol. 2020 May 12;75(18):2372-2375. doi: 10.1016/j.jacc.2020.03.021. Epub 2020 Mar 19.
10
Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China.2019年冠状病毒病(COVID-19)疫情对中国香港ST段抬高型心肌梗死治疗的影响
Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631. doi: 10.1161/CIRCOUTCOMES.120.006631. Epub 2020 Mar 17.